Rocket Lab's Stellar Run Meets Insider Cash-Out and Sector Turbulence

Rocket Lab’s ascent to an all-time high of $151 this week reflects a classic clash: the company is landing major contracts and pushing into new markets, yet its own leadership is selling millions of dollars in shares. The stock closed Friday at $143.48, down 3.1% on the day, after a dizzying month that more than doubled its price. That record level proved fleeting, and further pressure emerged from a separate session that saw the stock fall 4.16% to $141.87, driven by fresh insider sales and a violent launch-site accident at a rival firm.

The pullback came even as the company executed on two fronts. On May 29, Rocket Lab closed the acquisition of Motiv Space Systems, rebranding the robotics specialist as Rocket Lab Robotics. Motiv’s Mars-qualified robotic arms will expand the company’s capabilities beyond launch services. That same week, the firm passed a key system requirements review for an $816 million contract with the U.S. Space Development Agency to build 18 satellites. The overall order backlog now stands at $2.2 billion.

But while the order book swells, executives have been steadily reducing their exposure. Securities filings show that insiders sold a combined $43.5 million in shares during May alone. Chief Financial Officer Adam Spice unloaded 62,744 shares at an average price of $142.57, netting about $8.95 million. Senior Vice President Arjun Kampani sold 70,000 shares at $145.13 for $10.16 million, and President Marvin Bradford Clevenger offloaded 15,138 shares worth $2.16 million. Many of these trades were conducted under prearranged plans, partly to cover taxes on vested options. Over the past 90 days, total insider sales amount to roughly $60 million. Spice still holds nearly a million shares directly.

Institutional investors, by contrast, have been buying. Legal & General Group Plc boosted its stake by 20.3% in the fourth quarter, to 1.04 million shares. Ilmarinen Mutual Pension Insurance and Fidelis Capital Partners also added to their positions. Institutions now own 71.78% of Rocket Lab’s shares, while 45 hedge funds maintain positions.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

The broader space sector took a hit on May 29 when a Blue Origin New Glenn rocket exploded during a static-fire test. Rocket Lab’s shares lost as much as 6% intraday, though they pared some losses. Peers such as AST SpaceMobile and Redwire suffered double-digit declines. The incident underscored the industry’s volatility, a trait Rocket Lab’s stock embodies with a beta of 2.3 — more than double the market’s typical swings.

Operationally, the company is making progress on its heavy-lift Neutron rocket, but not as quickly as hoped. After a failed tank test, the maiden flight has been pushed back to the fourth quarter of 2026 from an earlier target of the first quarter. Neutron is critical for competing in the heavy payload market, and until it reaches the pad, Rocket Lab remains heavily dependent on its smaller Electron vehicle and satellite programs.

Revenue for the most recent quarter rose 63.4% year over year to $200.35 million, while the net loss came in at $0.07 per share, in line with expectations. Despite the top-line growth, valuation has stretched to extremes. The stock now trades 102% above its 200-day moving average, a classic overheating signal. The market capitalization has swelled to approximately $83 billion, making Rocket Lab one of the most valuable privately controlled space firms.

Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.

Analysts remain cautious. The consensus rating is “Moderate Buy,” but the average price target stands at $97.19 — more than 32% below current levels. Some models suggest the stock is priced nearly 98% above its fair value. The stock’s 50-day moving average is already 55% beneath the market price, and the relative strength index of 61 points to a neutral reading rather than outright overbought territory.

With an upcoming SpaceX IPO fanning sector-wide enthusiasm and new U.S. Space Force contracts on the horizon, Rocket Lab benefits from powerful tailwinds. Yet insider selling, a delayed rocket, and a rich valuation leave the stock vulnerable to sharp corrections. The $150 level — the 52-week high reached on May 27 — is now a formidable resistance point that will test whether the bulls can regain control.

Ad

Rocket Lab USA Stock: New Analysis - 30 May

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | ROCKET | boerse | 69449515 |